These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 10233426

  • 1. Erythropoietic activity in patients with sickle cell anaemia before and after treatment with hydroxyurea.
    Ballas SK, Marcolina MJ, Dover GJ, Barton FB.
    Br J Haematol; 1999 May; 105(2):491-6. PubMed ID: 10233426
    [Abstract] [Full Text] [Related]

  • 2. Early detection of response to hydroxyurea therapy in patients with sickle cell anemia.
    Ballas SK, McCarthy WF, Guo N, Brugnara C, Kling G, Bauserman RL, Waclawiw MA.
    Hemoglobin; 2010 May; 34(5):424-9. PubMed ID: 20854115
    [Abstract] [Full Text] [Related]

  • 3. Mechanism of action of hydroxyurea in the management of sickle cell anemia in adults.
    Charache S.
    Semin Hematol; 1997 Jul; 34(3 Suppl 3):15-21. PubMed ID: 9317197
    [Abstract] [Full Text] [Related]

  • 4. Modulation of erythrocyte arginase activity in sickle cell disease patients during hydroxyurea therapy.
    Iyamu EW, Cecil R, Parkin L, Woods G, Ohene-Frempong K, Asakura T.
    Br J Haematol; 2005 Nov; 131(3):389-94. PubMed ID: 16225659
    [Abstract] [Full Text] [Related]

  • 5. Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive "switching" agent. The Multicenter Study of Hydroxyurea in Sickle Cell Anemia.
    Charache S, Barton FB, Moore RD, Terrin ML, Steinberg MH, Dover GJ, Ballas SK, McMahon RP, Castro O, Orringer EP.
    Medicine (Baltimore); 1996 Nov; 75(6):300-26. PubMed ID: 8982148
    [Abstract] [Full Text] [Related]

  • 6. Determinants of red cell survival and erythropoietic activity in patients with sickle cell anemia in the steady state.
    Ballas SK, Marcolina MJ.
    Hemoglobin; 2000 Nov; 24(4):277-86. PubMed ID: 11186257
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effect of hydroxyurea on immature reticulocyte fraction in sickle cell anemia.
    Bagdasaryan R, Glasser L, Quillen K, Chaves F, Xu D.
    Lab Hematol; 2007 Nov; 13(3):93-7. PubMed ID: 17984040
    [Abstract] [Full Text] [Related]

  • 10. Hydroxyurea in the treatment of sickle-cell anemia.
    Howard LW, Kennedy LD.
    Ann Pharmacother; 1997 Nov; 31(11):1393-6. PubMed ID: 9391697
    [Abstract] [Full Text] [Related]

  • 11. Fetal hemoglobin in sickle cell anemia: genetic determinants of response to hydroxyurea.
    Ma Q, Wyszynski DF, Farrell JJ, Kutlar A, Farrer LA, Baldwin CT, Steinberg MH.
    Pharmacogenomics J; 2007 Dec; 7(6):386-94. PubMed ID: 17299377
    [Abstract] [Full Text] [Related]

  • 12. Use of hydroxyurea in children with sickle cell disease: what comes next?
    Ohene-Frempong K, Smith-Whitley K.
    Semin Hematol; 1997 Jul; 34(3 Suppl 3):30-41. PubMed ID: 9317199
    [Abstract] [Full Text] [Related]

  • 13. Reduction of the clinical severity of sickle cell/beta-thalassemia with hydroxyurea: the experience of a single center in Greece.
    Loukopoulos D, Voskaridou E, Kalotychou V, Schina M, Loutradi A, Theodoropoulos I.
    Blood Cells Mol Dis; 2000 Oct; 26(5):453-66. PubMed ID: 11112383
    [Abstract] [Full Text] [Related]

  • 14. Hydroxyurea (HU) for prevention of recurrent stroke in sickle cell anemia (SCA).
    Sumoza A, de Bisotti R, Sumoza D, Fairbanks V.
    Am J Hematol; 2002 Nov; 71(3):161-5. PubMed ID: 12410569
    [Abstract] [Full Text] [Related]

  • 15. Effects of hydroxyurea in a population of Brazilian patients with sickle cell anemia.
    Vicari P, Barretto de Mello A, Figueiredo MS.
    Am J Hematol; 2005 Mar; 78(3):243-4. PubMed ID: 15726590
    [Abstract] [Full Text] [Related]

  • 16. Hydroxyurea therapy in sickle cell anemia patients aids to maintain oral fungal colonization balance.
    Salvia AC, Figueiredo MS, Braga JA, Pereira DF, Brighenti FL, Koga-Ito CY.
    J Oral Pathol Med; 2013 Aug; 42(7):570-5. PubMed ID: 23278631
    [Abstract] [Full Text] [Related]

  • 17. Hydroxyurea in children: present and future.
    Vichinsky EP.
    Semin Hematol; 1997 Jul; 34(3 Suppl 3):22-9. PubMed ID: 9317198
    [Abstract] [Full Text] [Related]

  • 18. Reticulocyte parameters and hemoglobin F production in sickle cell disease patients undergoing hydroxyurea therapy.
    Borba R, Lima CS, Grotto HZ.
    J Clin Lab Anal; 2003 Jul; 17(2):66-72. PubMed ID: 12640630
    [Abstract] [Full Text] [Related]

  • 19. Effects of hydroxyurea on the membrane of erythrocytes and platelets in sickle cell anemia.
    Covas DT, de Lucena Angulo I, Vianna Bonini Palma P, Zago MA.
    Haematologica; 2004 Mar; 89(3):273-80. PubMed ID: 15020264
    [Abstract] [Full Text] [Related]

  • 20. [Effect of hydroxyurea on hemoglobin S].
    Torres AF, Eberle SE, Sciuccati G, Bonduel M.
    Medicina (B Aires); 2003 Mar; 63(2):140-2. PubMed ID: 12793083
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.